Pub Date : 2018-10-25DOI: 10.29011/2688-8769.000007
Y. Diallo, M. Diallo, S. Kouka, M. Faye, Ndeye Sow, M. N'diaye, C. Diop, M. Daher, R. Ly, S. Diaw, A. Diamé, C. Sylla
Introduction: Obstetric vesico-vaginal fistula is an abnormal communication between the bladder and the vagina as a complication of obstructed labour. The aim of this work is to show the role of ambulatory surgery in the treatment of VVF. Patients and Methods: This is a prospective study over a period of 4 years from 01 January 2011 to 31 December 2014, with 21 cases of VVF patients with simple obstetric outpatient treatment. The average age of patients was 24 years, ranging from 15 to 45 years. The technique used was that of Bracquehaye modified. All patients were kept for a day in hospital without an indwelling urinary catheter. Results: Out of a total of 115 fistula patients, 38 of them had simple VVF representing 33%. Among the simple cases, 21 patients underwent surgical treatment as outpatients, accounting for 55.26%. The average time before surgery was 5 years, with a range ranging of 2 months to 20 years. Of all the simple VVF patients operated on outpatient’s basis, we recorded a 90.5% rate of good outcome (n=19). Patients were followed over a period of 1 to 5 years. Conclusion: Obstetric VVF is a public health problem. Ambulatory surgery has advantages in that it reduces the indwelling and hospital stay.
{"title":"Evaluation of Ambulatory Treatment of Simple Vesico-Vaginal Fistulas","authors":"Y. Diallo, M. Diallo, S. Kouka, M. Faye, Ndeye Sow, M. N'diaye, C. Diop, M. Daher, R. Ly, S. Diaw, A. Diamé, C. Sylla","doi":"10.29011/2688-8769.000007","DOIUrl":"https://doi.org/10.29011/2688-8769.000007","url":null,"abstract":"Introduction: Obstetric vesico-vaginal fistula is an abnormal communication between the bladder and the vagina as a complication of obstructed labour. The aim of this work is to show the role of ambulatory surgery in the treatment of VVF. Patients and Methods: This is a prospective study over a period of 4 years from 01 January 2011 to 31 December 2014, with 21 cases of VVF patients with simple obstetric outpatient treatment. The average age of patients was 24 years, ranging from 15 to 45 years. The technique used was that of Bracquehaye modified. All patients were kept for a day in hospital without an indwelling urinary catheter. Results: Out of a total of 115 fistula patients, 38 of them had simple VVF representing 33%. Among the simple cases, 21 patients underwent surgical treatment as outpatients, accounting for 55.26%. The average time before surgery was 5 years, with a range ranging of 2 months to 20 years. Of all the simple VVF patients operated on outpatient’s basis, we recorded a 90.5% rate of good outcome (n=19). Patients were followed over a period of 1 to 5 years. Conclusion: Obstetric VVF is a public health problem. Ambulatory surgery has advantages in that it reduces the indwelling and hospital stay.","PeriodicalId":389483,"journal":{"name":"Advances in Andrology & Gynaecology","volume":"92 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2018-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126729306","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2018-09-14DOI: 10.13188/2332-3442.1000035
E. Erdem
Introduction: Varicocele is the most common and correctable cause of male infertility. Microscopic subinguinal varicocelectomy is the golden standard in the treatment of this disease, and recurrence is the most common complication. The aim of this study was to investigate the outcomes of microscopic varicocelectomy in primary and recurrent varicocele. Materials and Methods: The data of 20 patients undergoing left subinguinal microscopic varicocelectomy due to left varicocele for the first time and 20 patients undergoing the same operation for the second time due to recurrence between April 2015 and May 2017, were retrospectively evaluated. Semen analyses, testicular volumes and complication rates were compared between the groups both prior to and 12 months after the operation. Findings: The mean age was 30.2±1.4 in the primary varicocele group and 31.3±1.1 in the recurrent varicocele group (p>0.05). No significant difference was observed between the preand the post-operative values of testicular volume in patients undergoing primary microscopic varicocelectomy (3.2±1.4 ml and 3.1±1.7 ml, respectively; p>0.05); however, a significant improvement was observed in sperm count, motility and morphology parameters (10.3±2.9 millions/ml, 28.2±7.8%, 2.2±1.4% and 11.3±3.3 millions/ ml, 30.2±6.8%, 2.5±1.8%, p<0.05). In the recurrent varicocele group, no significant difference was observed between the preand post-operative semen volume (3.23±1.7 ml and 2.4±1.6 ml, p>0.05), whereas a significant improvement was observed in sperm concentration, morphology and motility parameters (9.6±3.3 millions/ml, 20.3±4.5%, 2.3±1.7% and 11.6±2.6 millions/ml, 23.2±7.5%, 2.5±1.9%, p<0.05). The testicular volume was observed to have increased in the post-operative period in both primary and recurrent varicocele groups (12.5±2.6 ml and 13.2±3.4 ml vs (11.8±2.4 ml and 12.3±2.7 ml), which was not statistically significant (p>0.05). Conclusion: Microscopic subinguinal varicocelectomy, which is related to the highest success rates and lowest recurrence and complication rates in the treatment of varicocele, may be safely used in the treatment of recurrent varicocele as well. Introduction Varcicocele is one of the most common and correctable pathologies observed in males presenting to urology clinics due to infertility [1]. The incidence in the normal population is 10-15%; however, it may be as high as 40% among patients with primary infertility and 80% among those with secondary infertility [2]. Varicocele is characterized by impairment in sperm count, motility and morphology parameters, reduced testicular volume and Leydig cell dysfunction, and leads to infertility [3]. The disease should be treated in case of diagnosed varicocele in the patient with infertility via physical examination or radiological imaging, if more than one parameter in seminal analysis is impaired and when no pathology that may lead to infertility is detected in his sexual partner [3,4]. One of the most commo
{"title":"Evaluating the Efficay of Microscopic Varicocelectomy in the Treatment of Primary and Recurrent Varicocele","authors":"E. Erdem","doi":"10.13188/2332-3442.1000035","DOIUrl":"https://doi.org/10.13188/2332-3442.1000035","url":null,"abstract":"Introduction: Varicocele is the most common and correctable cause of male infertility. Microscopic subinguinal varicocelectomy is the golden standard in the treatment of this disease, and recurrence is the most common complication. The aim of this study was to investigate the outcomes of microscopic varicocelectomy in primary and recurrent varicocele. Materials and Methods: The data of 20 patients undergoing left subinguinal microscopic varicocelectomy due to left varicocele for the first time and 20 patients undergoing the same operation for the second time due to recurrence between April 2015 and May 2017, were retrospectively evaluated. Semen analyses, testicular volumes and complication rates were compared between the groups both prior to and 12 months after the operation. Findings: The mean age was 30.2±1.4 in the primary varicocele group and 31.3±1.1 in the recurrent varicocele group (p>0.05). No significant difference was observed between the preand the post-operative values of testicular volume in patients undergoing primary microscopic varicocelectomy (3.2±1.4 ml and 3.1±1.7 ml, respectively; p>0.05); however, a significant improvement was observed in sperm count, motility and morphology parameters (10.3±2.9 millions/ml, 28.2±7.8%, 2.2±1.4% and 11.3±3.3 millions/ ml, 30.2±6.8%, 2.5±1.8%, p<0.05). In the recurrent varicocele group, no significant difference was observed between the preand post-operative semen volume (3.23±1.7 ml and 2.4±1.6 ml, p>0.05), whereas a significant improvement was observed in sperm concentration, morphology and motility parameters (9.6±3.3 millions/ml, 20.3±4.5%, 2.3±1.7% and 11.6±2.6 millions/ml, 23.2±7.5%, 2.5±1.9%, p<0.05). The testicular volume was observed to have increased in the post-operative period in both primary and recurrent varicocele groups (12.5±2.6 ml and 13.2±3.4 ml vs (11.8±2.4 ml and 12.3±2.7 ml), which was not statistically significant (p>0.05). Conclusion: Microscopic subinguinal varicocelectomy, which is related to the highest success rates and lowest recurrence and complication rates in the treatment of varicocele, may be safely used in the treatment of recurrent varicocele as well. Introduction Varcicocele is one of the most common and correctable pathologies observed in males presenting to urology clinics due to infertility [1]. The incidence in the normal population is 10-15%; however, it may be as high as 40% among patients with primary infertility and 80% among those with secondary infertility [2]. Varicocele is characterized by impairment in sperm count, motility and morphology parameters, reduced testicular volume and Leydig cell dysfunction, and leads to infertility [3]. The disease should be treated in case of diagnosed varicocele in the patient with infertility via physical examination or radiological imaging, if more than one parameter in seminal analysis is impaired and when no pathology that may lead to infertility is detected in his sexual partner [3,4]. One of the most commo","PeriodicalId":389483,"journal":{"name":"Advances in Andrology & Gynaecology","volume":"3 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2018-09-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115346068","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2018-08-15DOI: 10.29011/2688-8769.000005
G. Zwang
One could state that, once her sexual adult life established, “normally opened out woman”, provided with a normally confident character, as well as a loving and attentive companion, assumes without major concern the aspect and the function of her sex. A good understanding between both gets generally established their getting on for thirty. It seems not the case for a certain number of some women anxious about their aspect and functions. The feminine press echoes abut misunderstandings which seem to be in incontestable recrudescence. This article has been dictated by the author due to recent interviews with managers of the medias: they asked questions which they thought answered since a long time. The beginning of this questioning was about a triplet influence: the persistence in the mentality of a certain macho conformism, a restoring of a certain puritanism awaking the antic mistrust towards sex since the outbreak of aids and last but not least a conformist obedience to a certain kind of mode like the snobbery appearing at housewives of less than fifty years. The women’s sex, which is always the victim in common places, has too often difficulties to be accepted as it is. The author proposes arguments and certain resources to help the anxious to assume it.
{"title":"The Adult Woman and Her Sex: A Not Always Cordial Feeling","authors":"G. Zwang","doi":"10.29011/2688-8769.000005","DOIUrl":"https://doi.org/10.29011/2688-8769.000005","url":null,"abstract":"One could state that, once her sexual adult life established, “normally opened out woman”, provided with a normally confident character, as well as a loving and attentive companion, assumes without major concern the aspect and the function of her sex. A good understanding between both gets generally established their getting on for thirty. It seems not the case for a certain number of some women anxious about their aspect and functions. The feminine press echoes abut misunderstandings which seem to be in incontestable recrudescence. This article has been dictated by the author due to recent interviews with managers of the medias: they asked questions which they thought answered since a long time. The beginning of this questioning was about a triplet influence: the persistence in the mentality of a certain macho conformism, a restoring of a certain puritanism awaking the antic mistrust towards sex since the outbreak of aids and last but not least a conformist obedience to a certain kind of mode like the snobbery appearing at housewives of less than fifty years. The women’s sex, which is always the victim in common places, has too often difficulties to be accepted as it is. The author proposes arguments and certain resources to help the anxious to assume it.","PeriodicalId":389483,"journal":{"name":"Advances in Andrology & Gynaecology","volume":"27 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2018-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127966903","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2018-08-05DOI: 10.29011/2688-8769.000004
G. Cavallini, G. Biagiotti
This is a prospective placebo-controlled study to test the efficacy and safety of a dietary supplement (Vigoryx®, FG. -Pharma, Rome-Italy) for men with Psychogenic Hypoactive Sexual Desire (pHSD). The composition of Vigoryx was as follows: selenium 55 mg, L-Carnitine 250 mg, red ginseng 135 mg, aframomum 20 mg and eruca 300 mg. This is a two-center prospective blind placebo-controlled study. All patients affected by pHSD were considered to be candidates. Sexual desire was assessed in each patient before and after active drug or placebo administration using the International Index of Erectile Function (IIEF15, items 11 and 12) and Patient Global Impression of Improvement (PGI-I, seven grade scale) scores. The patients received Vigoryx® (active drug, Group 1) or a control substance (alimentary starch, Group 2). The differences between the unmatched groups were assessed using the Mann-Whitney Rank test, and the differences between before and after (matched groups) therapy were assessed using the Wilcoxon Signed Rank test. The side effects were compared between the two groups using the chi2 test. Eighty-four patients were studied. Forty patients used Vigoryx (Group 1), and 44 used a placebo (Group 2). No significant differences existed between the basal IIEF scores, and between the basal scores and the score achieved after a three-month administration of the control substance; on the other hand, the IIEF score after a three-month administration of Vigoryx was significantly higher than the basal scores and the score achieved after control substance administration. Furthermore, the PGI-I score achieved after active drug administration was significantly higher than the PGI-I score achieved after starch administration. No side effects emerged in either group. Vigoryx is a safe and efficient drug for the treatment of pHSD.
{"title":"Phytotherapy of Male Hypoactive Sexual Desire of Psychogenic Origin: A Preliminary Study","authors":"G. Cavallini, G. Biagiotti","doi":"10.29011/2688-8769.000004","DOIUrl":"https://doi.org/10.29011/2688-8769.000004","url":null,"abstract":"This is a prospective placebo-controlled study to test the efficacy and safety of a dietary supplement (Vigoryx®, FG. -Pharma, Rome-Italy) for men with Psychogenic Hypoactive Sexual Desire (pHSD). The composition of Vigoryx was as follows: selenium 55 mg, L-Carnitine 250 mg, red ginseng 135 mg, aframomum 20 mg and eruca 300 mg. This is a two-center prospective blind placebo-controlled study. All patients affected by pHSD were considered to be candidates. Sexual desire was assessed in each patient before and after active drug or placebo administration using the International Index of Erectile Function (IIEF15, items 11 and 12) and Patient Global Impression of Improvement (PGI-I, seven grade scale) scores. The patients received Vigoryx® (active drug, Group 1) or a control substance (alimentary starch, Group 2). The differences between the unmatched groups were assessed using the Mann-Whitney Rank test, and the differences between before and after (matched groups) therapy were assessed using the Wilcoxon Signed Rank test. The side effects were compared between the two groups using the chi2 test. Eighty-four patients were studied. Forty patients used Vigoryx (Group 1), and 44 used a placebo (Group 2). No significant differences existed between the basal IIEF scores, and between the basal scores and the score achieved after a three-month administration of the control substance; on the other hand, the IIEF score after a three-month administration of Vigoryx was significantly higher than the basal scores and the score achieved after control substance administration. Furthermore, the PGI-I score achieved after active drug administration was significantly higher than the PGI-I score achieved after starch administration. No side effects emerged in either group. Vigoryx is a safe and efficient drug for the treatment of pHSD.","PeriodicalId":389483,"journal":{"name":"Advances in Andrology & Gynaecology","volume":"52 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2018-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"117059614","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"To Cultivate Neourethra of Autologous for Proximal Hypospadias Repair of No Associated with Severe Chordee","authors":"Guoqing Liu, Shihui Liu, Shilin Zhang, Jianfeng Wang, Jierong Li, Chunjing Li","doi":"10.29011/2688-8769.000002","DOIUrl":"https://doi.org/10.29011/2688-8769.000002","url":null,"abstract":"","PeriodicalId":389483,"journal":{"name":"Advances in Andrology & Gynaecology","volume":"41 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2018-07-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121773560","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2018-07-03DOI: 10.29011/2688-8769.000003
{"title":"Hydroelectrophoresis for Transdermal Administration of Verapamile or of Hyaluronic Acid in Peyronie's Disease: A Prospective, Open Label, Multicenter Study","authors":"","doi":"10.29011/2688-8769.000003","DOIUrl":"https://doi.org/10.29011/2688-8769.000003","url":null,"abstract":"","PeriodicalId":389483,"journal":{"name":"Advances in Andrology & Gynaecology","volume":"17 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2018-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124164187","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：